浙江诗华诺倍威生物技术有限公司新增年产6800万毫升疫苗技术改造项目环境影响评价公示
在 诗华资讯 部分
-
Corporate Website
-
Africa
-
Argentina
-
Asia
-
Australia
-
Belgium
-
Brazil
-
Bulgaria
-
Canada (EN)
-
Chile
-
China
-
Colombia
-
Denmark
-
Egypt
-
France
-
Germany
-
Greece
-
Hungary
-
Indonesia
-
Italia
-
India
-
Japan
-
Korea
-
Malaysia
-
Mexico
-
Middle East
-
Netherlands
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Romania
-
Russia
-
South Africa
-
Spain
-
Sweden
-
Thailand
-
Tunisia
-
Turkey
-
Ukraine
-
United Kingdom
-
USA
-
Vietnam
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
-
Corporate Website
-
Africa
-
Argentina
-
Asia
-
Australia
-
Belgium
-
Brazil
-
Bulgaria
-
Canada (EN)
-
Chile
-
China
-
Colombia
-
Denmark
-
Egypt
-
France
-
Germany
-
Greece
-
Hungary
-
Indonesia
-
Italia
-
India
-
Japan
-
Korea
-
Malaysia
-
Mexico
-
Middle East
-
Netherlands
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Romania
-
Russia
-
South Africa
-
Spain
-
Sweden
-
Thailand
-
Tunisia
-
Turkey
-
Ukraine
-
United Kingdom
-
USA
-
Vietnam
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.